1. Home
  2. CRBP vs HITI Comparison

CRBP vs HITI Comparison

Compare CRBP & HITI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

CRBP

Corbus Pharmaceuticals Holdings Inc.

N/A

Current Price

$5.42

Market Cap

190.3M

Sector

Health Care

ML Signal

N/A

Logo High Tide Inc.

HITI

High Tide Inc.

N/A

Current Price

$2.62

Market Cap

220.6M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
CRBP
HITI
Founded
2009
2009
Country
United States
Canada
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
190.3M
220.6M
IPO Year
2014
2021

Fundamental Metrics

Financial Performance
Metric
CRBP
HITI
Price
$5.42
$2.62
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
10
7
Target Price
★ $34.03
$4.67
AVG Volume (30 Days)
★ 1.1M
833.8K
Earning Date
11-11-2026
09-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
N/A
★ N/A
Revenue
★ $4,822,272.00
N/A
Revenue This Year
N/A
$27.52
Revenue Next Year
$116.00
$10.52
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 97.62
N/A
52 Week Low
$5.13
$2.02
52 Week High
$20.56
$3.60

Technical Indicators

Market Signals
Indicator
CRBP
HITI
Relative Strength Index (RSI) 23.84 48.28
Support Level N/A $2.40
Resistance Level $8.13 $2.63
Average True Range (ATR) 0.42 0.11
MACD -0.10 -0.02
Stochastic Oscillator 10.17 30.43

Price Performance

Historical Comparison
CRBP
HITI

About CRBP Corbus Pharmaceuticals Holdings Inc.

Corbus Pharmaceuticals Holdings Inc is a clinical stage company focused on new therapies in oncology and obesity and is committed to helping people defeat serious illness by bringing inventive scientific approaches to well-understood biological pathways. The company's development pipeline includes; CRB-701, a next-generation antibody-drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload, CRB-601, an anti-integrin monoclonal antibody that blocks the activation of TGF expressed on cancer cells, and CRB-913 a second-generation peripherally restricted CB1 receptor inverse agonist designed to treat obesity.

About HITI High Tide Inc.

High Tide Inc is a downstream-focused retailer of cannabis products, distributor, and seller of smoking accessories and cannabis lifestyle products. It is a vertically integrated company in the Canadian cannabis market with various brands in its portfolio such as Canna Cabana, Fastendr, Queen of Bud, Grasscity, Daily High Club, and others. The company's reportable operating segments are: Bricks and mortar, which generates maximum revenue, and E-commerce. Geographically, it derives maximum revenue from its business in Canada, followed by the United States of America, and other international markets.

Share on Social Networks: